Results 161 to 170 of about 5,663,674 (349)
BioéthiqueOnline, 2013 Some patient interest groups and other pressure groups in the health sector solicit the pharmaceutical industry to obtain funding. I raise and discuss some issues that can result from this type of relationship.
Hughes, David
doaj
The Bundesbank's Communications Strategy and Policy Conflicts with the Federal Government [PDF]
In this paper we provide an estimate of the likelihood of conflict between the federal government and the Bundesbank for the 1989 – 1998 period. We rely on a novel proxy for the impact of public communication by Bundesbank officials on the probability of
Bohl, Martin T., Siklos, Pierre L.
core
Molecular Oncology, EarlyView.Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu +11 more
wiley +1 more source
US journal embroiled in another conflict of interest scandal
, 1998 D. Josefson
openalex +2 more sources
Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases11The authors declared not to have conflict of interest [PDF]
, 2001 Yvonne Bury +5 more
openalex +1 more source
Molecular Oncology, EarlyView.This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani +14 more
wiley +1 more source
Bankers on Boards: Monitoring, Conflicts of Interest, and Lender Liability
, 1999 Randall S. Kroszner, Philip E. Strahan
openalex +1 more source